New study tracks blood clot risks in rare autoimmune disease
NCT ID NCT07178925
First seen Nov 01, 2025 · Last updated Apr 24, 2026 · Updated 25 times
Summary
This study follows 200 adults with antiphospholipid syndrome (APS), a rare condition that increases blood clot risk. Researchers will track how often clots return and look at side effects from current treatments. The goal is to update old data and better understand real-world outcomes for these patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANTIPHOSPHOLIPID SYNDROME (APS) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University hospital of Rouen
RECRUITINGRouen, 76031, France
Conditions
Explore the condition pages connected to this study.